Zelira Therapeutics Ltd (ZLD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -16 | -28 | N/A | N/A | N/A |
| Net Acquisitions | 380 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 743 | 760 | 423 | -442 | -250 |
| Investing Cash Flow | $1,107 | $732 | $423 | $-442 | $-250 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | -211 | N/A |
| Common Stock Issued | 4,789 | N/A | 20 | 10,004 | 338 |
| Common Stock Repurchased | -287 | N/A | N/A | -605 | N/A |
| Financing Cash Flow | $4,502 | $N/A | $20 | $9,188 | $338 |
| Exchange Rate Effect | -49 | N/A | N/A | N/A | -25 |
| Beginning Cash Position | 3,073 | 5,686 | 7,868 | 722 | 325 |
| End Cash Position | 1,697 | 3,073 | 5,686 | 7,868 | 56 |
| Net Cash Flow | $-1,327 | $-2,613 | $-2,182 | $7,146 | $-244 |
| Free Cash Flow | |||||
| Capital Expenditure | N/A | N/A | N/A | -608 | N/A |
| Free Cash Flow | 0 | 0 | 0 | -608 | 0 |